Syngene International is launching a strategic collaboration with Johns Hopkins University to advance early-stage drug discovery. The CRDMO and the university will advance not only these programs, but also platform technologies from Johns Hopkins’ research labs. Syngene and Johns Hopkins Leverage Platforms Syngene plans to leverage its fully integrated discovery and development platform, SynVent, in the partnership. This platform, according to Syngene, addresses discovery biology, medicina...